Anne R. Pariser, M.D.
Anne Pariser, M.D. is the director of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Sciences (NCATS) NIH.
Anne R. Pariser, M.D. Read More »
Anne Pariser, M.D. is the director of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Sciences (NCATS) NIH.
Anne R. Pariser, M.D. Read More »
Henry Ford Health System in the US has opened the Brigitte Harris Cancer Pavilion
Dr Åslaug Helland, of Oslo University Hospital, joined us for our panel discussion on February 4 to discuss, ‘Innovative Clinical Trial Design for Precision Oncology’
Dr Åslaug Helland, of Oslo University Hospital speaks about IMPRESS Norway Read More »
Penilla Gunther, of FOKUS Patient joined us for our Virtual Panel Series discussion on February 4.
Penilla Gunther, of FOKUS Patient speaks about educating patients about clinical trials Read More »
Dr. Razelle Kurzrock, of UCSD Moores Cancer Center and University of California San Diego School of Medicine
Henry Ford Health System in the US has opened the Brigitte Harris Cancer Pavilion
The Henry Ford Cancer Institute opens facility to Advance Cancer Precision Medicine Read More »
Dany Bell, of Macmillan Cancer Support spoke to us about the work she does at Macmillan Cancer Support.
PMF Interviews Dany Bell, of Macmillan Cancer Support Read More »
Richard Ballerand is an Axolotl partner and digital engagement advocate. Passionate about patient and public involvement, he chairs the Patient and Public Voice group of the London Clinical Senate NHSEI.
This year’s guidelines for the regulation of Genomics data have been released by the European Observatory on Health Systems and Policies.
Larry) Mróz, PhD, Research Services Lead, BC SUPPORT (SUpport for People and Patient-Oriented Research and Trials), British Columbia